首页> 外国专利> Polymerisable phospholipids and polymers thereof, methods for their preparation, methods for their use in coating substrates and forming liposomes and the resulting coated substrates and liposome compositions

Polymerisable phospholipids and polymers thereof, methods for their preparation, methods for their use in coating substrates and forming liposomes and the resulting coated substrates and liposome compositions

机译:可聚合的磷脂及其聚合物,其制备方法,其在涂覆底物和形成脂质体中的使用方法以及所得的涂覆底物和脂质体组合物

摘要

New phospholipids containing a conjugated di-yne system have the formula:wherein at least one of 8, and B2 is a group of the formulawherein p is 0 or 1, X, is a direct bond or a divalent aliphatic or cycloaliphatic group, Y, is H or a monovalent aliphatic or cycloaliphatic group, the total number of carbon atoms in X, and Y, in each of B, and/or B2 being 8 to 26; and the other of B, and B2 is either (a) the same or a different group of the formulawhere X,, Y, or p are as defined above; or (b) is an aliphatic or cycloaliphatic group containing at least 8 carbon atoms; n is 0 or 1, m is 2, 3 or 4 and each R independently represents an alkyl group containing 1 to 4 carbon atoms, and are prepared by esterification and/or etherification of glycerol by conventional techniques. The conjugated di-yne systems can be cross-linked by actinic radiation to give intermolecular and, in certain cases, also intramolecular cross-linking. Thin layers of the phospholipids can be coated onto substrates subsequently to be brought into contact with blood or other body fluids and then cross-linked to give polymer coated surfaces which have a reduced tendency to initiate blood coagulation, for example, compared to untreated surfaces. Artificial lenses for the human eye treated in this way have a reduced tendency to cause endothelial damage. The phospholipids of the invention can also be formed into liposomes and the conjugated di-yne system then cross-linked. Physiologically active materials such as drugs, enzymes or antigens can be incorporated into the liposomes which can then be used as prolonged release formulations.
机译:含有共轭二炔系统的新磷脂具有下式: <图像文件=“ IMGA0001.GIF” he =“ 31” id =“ ia01” imgContent =“ chem” imgFormat =“ GIF” inline =“ no” wi =“ 61” /> < / Chemistry>,其中8,B 2 中的至少一个是下式的基团 <图像文件=“ IMGA0002.GIF” he =“ 6” id =“ ia02” imgContent =“ chem” imgFormat =“ GIF” inline =“ no” wi =“ 70” /> <化学式中,p为0或1,X为直键或二价脂族或脂环族基团,Y为H或一价脂族或脂环族基团,X中的碳原子总数分别为Y B,和/或B 2 为8到26; B的另一个,且B 2 是(a)公式的相同或不同基团 <图像文件=“ IMGA0003.GIF” he =“ 6” id =“ ia03” imgContent =“ chem” imgFormat =“ GIF” inline =“ no” wi =“ 52” /> <化学式中,X,Y或p如上定义; (b)为含有至少8个碳原子的脂族或脂环族基团;或n为0或1,m为2、3或4,并且每个R独立地表示含有1-4个碳原子的烷基,并且通过常规技术通过甘油的酯化和/或醚化制备。可以通过光化辐射使共轭二炔体系交联,以进行分子间交联,在某些情况下还可以进行分子内交联。可以将磷脂的薄层涂覆到基底上,然后使其与血液或其他体液接触,然后交联,以形成聚合物涂覆的表面,例如,与未处理的表面相比,该表面具有降低的引发凝血的趋势。用这种方法处理的用于人眼的人造晶状体引起内皮损伤的趋势降低。本发明的磷脂也可以形成脂质体,然后使缀合的二炔系统交联。可以将诸如药物,酶或抗原的生理活性物质掺入脂质体中,然后将其用作延长释放制剂。

著录项

  • 公开/公告号EP0032622A1

    专利类型

  • 公开/公告日1981-07-29

    原文格式PDF

  • 申请/专利号EP19800304571

  • 发明设计人 CHAPMAN DENNIS;

    申请日1980-12-17

  • 分类号C07F9/10;A61K9/52;A61K37/22;A61K31/685;C08F2/48;C08F2/54;C08F38/02;B05D5/00;G02B1/10;G02C7/04;

  • 国家 EP

  • 入库时间 2022-08-22 15:37:12

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号